MX9306392A - Composicion y metodo para evitar la sobredosis de acetaminofen - Google Patents

Composicion y metodo para evitar la sobredosis de acetaminofen

Info

Publication number
MX9306392A
MX9306392A MX9306392A MX9306392A MX9306392A MX 9306392 A MX9306392 A MX 9306392A MX 9306392 A MX9306392 A MX 9306392A MX 9306392 A MX9306392 A MX 9306392A MX 9306392 A MX9306392 A MX 9306392A
Authority
MX
Mexico
Prior art keywords
acetaminophen
acetaminofen
composition
diallyl
daso2
Prior art date
Application number
MX9306392A
Other languages
English (en)
Inventor
C S Yang
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of MX9306392A publication Critical patent/MX9306392A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe un método para prevenir la hepatotoxicidad inducida por acetaminofén o acetaminoféno (ADAP) utilizando sulfuro de dialilo (DAS) y sulfona de dialilo (DASO2). Se preparan DAS y DASO2 como una modalidad preferida, se agrega sulfona de dialilo a una forma de dosificción de acetaminofén en una cantidad efectiva para evitar el metabolismo de tal dosis unitaria de acetaminofén en sus metabolitos anteriores incluyen de manera adicional una cantidad efectiva de N-acetilcisteína para destoxificar metabolitos hepatotóxicos de acetaminofén.
MX9306392A 1992-10-16 1993-10-14 Composicion y metodo para evitar la sobredosis de acetaminofen MX9306392A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/962,529 US5474757A (en) 1992-10-16 1992-10-16 Prevention of acetaminophen overdose toxicity with organosulfur compounds

Publications (1)

Publication Number Publication Date
MX9306392A true MX9306392A (es) 1994-05-31

Family

ID=25506019

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306392A MX9306392A (es) 1992-10-16 1993-10-14 Composicion y metodo para evitar la sobredosis de acetaminofen

Country Status (4)

Country Link
US (1) US5474757A (es)
AU (1) AU5442094A (es)
MX (1) MX9306392A (es)
WO (1) WO1994008628A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305058D0 (en) * 1993-03-12 1993-04-28 Penn Pharm Ltd Pharmaceutical compositions
KR100405116B1 (ko) * 1995-02-28 2004-02-05 아벤티스 파마슈티칼스 인크. 피페리디노알칸올화합물에대한약제학적조성물
FR2744917B1 (fr) * 1996-02-16 1998-04-10 Kouchner Gerard Composition therapeutique a base d'acetaminophene
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US6048540A (en) * 1997-01-29 2000-04-11 Chong Kun Dang Corp. Acetamenophen composition with reduced liver toxicity
TR200000517T2 (tr) * 1997-08-26 2000-08-21 Hoechst Marion Roussel, Inc. Piperidinoalkanol-Konjesyon azaltıcıdan oluşan kombinasyona yönelik farmasötik kompozisyon.
US20070141181A1 (en) 1998-02-13 2007-06-21 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
US6797289B2 (en) 1998-02-13 2004-09-28 Nutramax Laboratories, Inc. Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
WO1999043336A1 (en) 1998-02-27 1999-09-02 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US20010000472A1 (en) * 1998-02-27 2001-04-26 Nutramax Laboratories, Inc. L-ergothioneine, milk thistle, and s-adenosylmethionine for the prevention, treatment and repair of liver damage
US6245336B1 (en) 1999-03-11 2001-06-12 Dry Creek Nutrition, Inc. Prevention and treatment of acetaminophen toxicity with grape seed proanthocyanidin extract
US6281222B1 (en) 1999-08-19 2001-08-28 Inotek Corporation Compositions and method for treatment of acetaminophen intoxication
US6759062B2 (en) 2000-02-23 2004-07-06 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) 2000-02-23 2004-09-07 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6793942B2 (en) 2000-02-23 2004-09-21 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
US6841544B2 (en) * 2000-02-23 2005-01-11 Bioselect Innovations, Inc. Composition and method for treating the effects of diseases and maladies
KR100408107B1 (ko) * 2000-10-27 2003-12-01 정세영 류코시아니딘을 함유하는 간 보호용 약학 조성물
US6566401B2 (en) * 2001-03-30 2003-05-20 The Board Of Trustees Of The Leland Stanford Junior University N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
US20050220862A1 (en) 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
TWI273911B (en) * 2005-01-18 2007-02-21 Univ Nat Chiao Tung Prevention and amelioration of acetaminophen toxicity with tea melanin
AU2011202871B2 (en) * 2005-08-24 2014-06-12 Cumberland Pharmaceuticals Inc. Acetylcysteine composition and uses therefor
US8148356B2 (en) 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
WO2007044700A2 (en) * 2005-10-07 2007-04-19 Board Of Trustees Of Southern Illinois University Protectant combinations for reducing toxicities
US20080188439A1 (en) * 2006-10-26 2008-08-07 Salhanick Steven D Directed metabolism of compounds by glucuronidation and sulfonation donors to decrease toxicity
US20080139654A1 (en) * 2006-12-09 2008-06-12 Eric Mott Soderling Acetaminophen compositions having minimized side effects including reduced hepatotoxicity
ITMI20080187A1 (it) * 2008-02-07 2009-08-08 Velleja Res Srl Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo
BRPI0912820A2 (pt) * 2008-05-20 2015-10-13 Neurogesx Inc pró-fármacos de relação hepatoprotetora de acetaminofeno
CN105687177A (zh) 2009-07-15 2016-06-22 小利兰·斯坦福大学托管委员会 N-乙酰半胱氨酸组合物以及改善对乙酰氨基酚的治疗效能的方法
KR20240051283A (ko) 2013-12-24 2024-04-19 버지니아 커먼웰스 유니버시티 산소첨가된 콜레스테롤 술페이트 (ocs) 의 용도
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
WO2016025897A1 (en) * 2014-08-15 2016-02-18 Purdue Pharma L.P. Acetaminophen-containing analgesic formulations with reduced hepatotoxicity
CN112569214A (zh) * 2019-09-29 2021-03-30 山东大学 二烯丙基硫醚在制备预防和/或治疗肝纤维化及肝癌药物中的应用
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314989A (en) * 1980-05-07 1982-02-09 Rosen Gerald M Methionine sulfoxide amflioration of acetaminophen toxicity
US4307073A (en) * 1980-08-08 1981-12-22 The Research Foundation Of State University Of New York Method and composition for reducing the toxicity of acetaminophen

Also Published As

Publication number Publication date
WO1994008628A1 (en) 1994-04-28
AU5442094A (en) 1994-05-09
US5474757A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
MX9306392A (es) Composicion y metodo para evitar la sobredosis de acetaminofen
ES2162517T3 (es) Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia.
AR022065A1 (es) Tabletas masticables suaves
DE3674570D1 (de) N,n-dimethyl-1-(1-(4-chlorophenyl)-cyclobutyl)-3-methylbutylamin-hydrochlorid, monohydrat und pharmazeutische zusammensetzungen, welche diese enthalten.
DK197787D0 (da) Synergistisk kombination af amantadin og selegilin
ES2185817T3 (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato.
BR0015605A (pt) Composição e uso
EA200100541A1 (ru) Фармацевтическая композиция с модифицированным высвобождением сенсибилизатора к инсулину и других антидиабетических агентов
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
CO4790174A1 (es) Analogos del peptido lh-rh, sus usos y composiciones farmaceuticas que los contienen
DE60209152D1 (de) Pharmazeutische zusammensetzung, umfassend gabapentin oder ein analogon davon und ein alpha-aminoamid
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
DK0648120T3 (da) Anvendelse af phosphonater til behandling af osteoporose
ATE154235T1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
AR004494A1 (es) Una celula util para el tratamiento del dolor, un metodo para producirla, un organo bioartificial de la comprende y un metodo para preparar dicho organobioartificial
UY28154A1 (es) Composiciones y metodos de cuidado oral
NO962655D0 (no) Deutrerte virkestoffer i transdermal applikasjon
IT8223016A0 (it) Formulazioni farmaceutiche comprendenti insulina umana e proinsulina umana.
IT8223017A0 (it) Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano.
NO912271L (no) Somatostatinpreparater, deres fremstilling og anvendelse.
MX9307203A (es) COMPUESTOS ESTEROIDALES DE ACIL-3-CARBOXI-3,5-DIENO-17Ó Y 17ß -SUBSTITUIDOS.
RS50805B (sr) Upotreba fsh za lečenje neplodnosti
ES2033181B1 (es) Una tableta o capsula de herbicida para su aplicacion en arrozales.